MetaCap

Allarity Therapeutics (ALLR) vs BeyondSpring (BYSI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Allarity Therapeutics (ALLR) has outperformed BeyondSpring (BYSI) over the past year, losing 25.9% versus a loss of 82.8%. BeyondSpring is the larger company by market cap ($13.7 million vs $12.6 million), about 1.1 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ALLR-25.94%BYSI-82.77%
+74%-8%-90%
Nov 21, 20251 yearNov 20, 2026
ALLR-100.00%BYSI-93.29%
+5%-50%-105%
Dec 20, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ALLR versus BYSI key metrics
MetricALLRBYSI
Share price$0.785$0.33
Market cap$12.56M$13.66M
1-day change-9.25%-24.49%
YTD return-27.31%-79.75%
1-year return-25.94%-82.77%
5-year return—-97.70%
EPS (TTM)$-0.79$-0.20
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$320.00K$0
Net income (latest FY)$-11.23M$-1.01M
Operating margin-3939.06%—
Net margin-3509.69%—
52-week high$1.84$2.44
52-week low$0.769$0.299
Distance from 52-week high-57.34%-86.48%
Analyst consensusnone—
Avg. price target upside+1301.27%—
Average volume131.74K261.79K
Shares outstanding16.00M41.41M
Employees744
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • ALLR has outperformed BYSI by 56.8 percentage points over the past year.

About Allarity Therapeutics

ALLR stock →

Allarity Therapeutics, Inc., a clinical-stage precision medicine pharmaceutical company, focuses on developing anti-cancer therapeutics for patients with unmet medical needs in Denmark and the United States. The company develops drugs for the personalized treatment of cancer using drug-specific companion diagnostics generated by its proprietary drug response predictor (DRP) technology.

Health Care · Biotechnology: Pharmaceutical Preparations · 7 employees

About BeyondSpring

BYSI stock →

BeyondSpring Inc., a clinical stage biopharmaceutical company, focuses on developing and selling clinical-stage biopharmaceutical therapies focused on oncology and immunology. The company operates through two segments: the Plinabulin pipeline and the TPD platform.

Health Care · Biotechnology: Pharmaceutical Preparations · 44 employees

ALLR vs BYSI FAQ

Which is bigger, Allarity Therapeutics or BeyondSpring?

BeyondSpring (BYSI) is larger, with a market capitalization of $13.66M compared with $12.56M for Allarity Therapeutics (ALLR).

Which stock has performed better over the past year, ALLR or BYSI?

ALLR returned -25.94% over the past 12 months, compared with -82.77% for BYSI (price return, excluding dividends). Past performance does not predict future results.

Are Allarity Therapeutics and BeyondSpring in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons